NUVECTIS PHARMA INC (NVCT)

US67080T1088 - Common Stock

5.58  +0.19 (+3.53%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
20.26M22.90M19.23M12.89M10.00K
Research and Development
13.28M15.38M13.23M9.55M0.00
Selling, General, and Administrative Expenses
7.58M7.52M6.01M3.35M10.00K
Operating Income
-20.26M-22.90M-19.23M-12.89M-10.00K
Interest Income/Expense
890.00K637.00K150.00K0.00N/A
Income Before Taxes
-19.37M-22.26M-19.09M-12.89M-10.00K
Net Income
-19.37M-22.26M-19.09M-12.89M-10.00K
 
Per Share Data
EPS Diluted Total Ops
-1.16-1.43-1.51-53.70-0.04
Non GAAP EPS
-1.16-1.43N/AN/AN/A
 
Statistics

All data in USD

Charts